Skip to content

Clinical trials

Phase 1/2 Hematologic Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 1/2 Country / region: Canada Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20131
20141
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Constellation Pharmaceuticals1
Editas Medicine, Inc.1
Kiadis Pharma1
Novartis Pharmaceuticals1
Spark Therapeutics, Inc.1
The Hospital for Sick Children1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases6
Blood Coagulation Disorders2
Bone Marrow Diseases2
Genetic Diseases, Inborn2
Hemorrhagic Disorders2
Myeloproliferative Disorders2
Neoplasms2
Primary Myelofibrosis2
Thrombocythemia, Essential2
Anemia1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.